Eight new N-Hoveyda-type complexes were synthesized in yields of 67-92 % through reaction of [RuCl2 (NHC)(Ind)(py)] (NHC=1,3-bis(2,4,6-trimethylphenylimidazolin)-2-ylidene (SIMes) or 1,3-bis(2,6-diisopropylphenylimidazolin)-2-ylidene (SIPr), Ind=3-phenylindenylid-1-ene, py=pyridine) with various 1- or 1,2-substituted ferrocene compounds with vinyl and amine or imine substituents. The redox potentials of the respective complexes were determined; in all complexes an iron-centered oxidation reaction occurs at potentials close to E=+0.5 V. The crystal structures of the reduced and of the respective oxidized Hoveyda-type complexes were determined and show that the oxidation of the ferrocene unit has little effect on the ruthenium environment. Two of the eight new complexes were found to be switchable catalysts, in that the reduced form is inactive in the ring-opening metathesis polymerization of cis-cyclooctene (COE), whereas the oxidized complexes produce polyCOE. The other complexes are not switchable catalysts and are either inactive or active in both reduced and oxidized states.
The conformation of the N—H bond in the structure of the title compound (23DCPA), C8H7Cl2NO, is syn to either the ortho or meta chloro substituent. The geometric parameters of 23DCPA are similar to related amides. The amide H atom is simultaneously involved in an intramolecular hydrogen bond with the ortho Cl atom and an intermolecular hydrogen bond with the O atom of the carbonyl group.
Background: The metalloproteinases ADAM10 and ADAM17 are involved in various diseases: neurodegeneration, cancer and inflammation. Objective: The inhibition of these proteases is a promising target in the treatment of inflammation and cancer. Methods and Results: In this study, we present an improved synthesis of the ADAM10 reference inhibitor GI254023X with a higher overall yield, enhanced detection ability and increased acid stability, providing easier handling. Conclusion: This upscaled synthesis, free of diastereomeric intermediates, ensures single-batch identity, thus warranting its reproducibility in further biological investigations.
Four novel cobalt(II) complexes mimicking metalloenzyme active sites, novel C(14)H(22)Cl(12)Co(2)O(13)·2C(3)H(8)O (1), C(28)H(36)Cl(24)Co(4)O(28)·4C(4)H(8)O(2) (2), C(16)H(22)Cl(12)Co(2)O(13)·C(2)HCl(3)O(2) (3), C(16)H(22)Cl(12)Co(2)O(13) (4), and one known C(40)H(78)Cl(8)Co(2)O(17) (5) are composed of the same core of two high-spin cobalt(II) centers triply bridged by water and two trichloroacetato (1-4) or two pivalate (5) groups but differ in terminal ligands. The crystal structures of new compounds 1-4 belong to the space groups P ̅1, P2(1)/c, P ̅1, and Pbcn, respectively. All five investigated complexes contain Co atoms in distorted octahedral coordination. The complexes were characterized by magnetic susceptibility and magnetization measurements and by variable-temperature variable-field magnetic circular dichroism spectroscopy. Experimental data were analyzed in the frame of the theoretical model, which includes an unquenched orbital moment of the Co(II) ions. All investigated compounds are antiferromagnetically coupled with exchange constants in the range -1.5 to -2.1 cm(-1). However, there is a significant difference between the crystal-field-splitting parameters.
The reaction of 1-amino,4-hydroxy-pentiptycene with diacetyl or acenaphthene-1,2-dione gave the respective diimines, followed by alkylation of the hydroxyl groups, and cyclization of the alkylated diimines to the respective bispentiptycene-imidazolium salts NHC·HCl. The azolium salts, being precursors to N-heterocyclic carbenes, were converted into metal complexes [(NHC)MX] (MX = CuI, AgCl, AuCl) and [(NHC)IrCl(cod)] and [(NHC)IrCl(CO)2] in good yields. In the solid state [(NHC)AgCl] displays a bowl-shaped structure of the ligand with the metal center buried within the concave unit.
A mononuclear oxido-vanadium(iv) complex, [VO(L)2], has been synthesized and its interactions with DNA and BSA have been investigated experimentally and theoretically.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.